Current Protein Identity:Q02223 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1OQD Crystal structure of sTALL-1 and BCMA Deposited 2003-03-07 Assembly 1 Protein heterocomplex Heteromer;Protein × 108 PDB declaration: 108-meric(108) Consistent with protein count
Chain K 8–46(39 aa) Fragment:extracellular domain
Chain L 8–46(39 aa) Fragment:extracellular domain
Chain M 8–46(39 aa) Fragment:extracellular domain
Chain N 8–46(39 aa) Fragment:extracellular domain
Chain O 8–46(39 aa) Fragment:extracellular domain
Chain P 8–46(39 aa) Fragment:extracellular domain
Chain Q 8–46(39 aa) Fragment:extracellular domain
Chain R 8–46(39 aa) Fragment:extracellular domain
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 9;277 K;dioxane, pH 9.0, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 2.60 Å R-free 0.260
1XU2 The crystal structure of APRIL bound to BCMA Deposited 2004-10-25 Assembly 1 Protein heterocomplex Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain R 5–51(47 aa) Fragment:BCMA ECD
Chain S 5–51(47 aa) Fragment:BCMA ECD
Chain T 5–51(47 aa) Fragment:BCMA ECD
Not recorded NI NICKEL (II) ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 5;292 K;well solution: 0.1M MES, 5% Peg 8000, 10% Peg 1000, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 292K
Resolution 2.35 Å R-free 0.213
2KN1 Solution NMR Structure of BCMA Deposited 2009-08-11 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–50(49 aa) Fragment:residues 2-50
Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6;Ionic strength (raw mmCIF value) 10;Pressure ambient
NMR sample composition 900 uM BCMA, 10 mM sodium phosphate, 0.02 % sodium azide, 95% H2O, 5% D2O | 95% H2O/5% D2O
Resolution not provided
4ZFO J22.9-xi: chimeric mouse/human antibody against human BCMA (CD269) Deposited 2015-04-21 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain F 1–54(54 aa) Fragment:Extracellular (N-terminal) domain, UNP residues 1-54
Not recorded CU COPPER (II) ION × 1 BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293.15 K;1 microliter of the complex at 8 mg/ml with 2 microliters of 21% PEG 3350, 0.1 M BisTris pH 6.5 and 5 mM CuCl2
Resolution 1.90 Å R-free 0.209
4ZFO J22.9-xi: chimeric mouse/human antibody against human BCMA (CD269) Deposited 2015-04-21 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain K 1–54(54 aa) Fragment:Extracellular (N-terminal) domain, UNP residues 1-54
Not recorded CU COPPER (II) ION × 2 BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293.15 K;1 microliter of the complex at 8 mg/ml with 2 microliters of 21% PEG 3350, 0.1 M BisTris pH 6.5 and 5 mM CuCl2
Resolution 1.90 Å R-free 0.209
6J7W Crystal Structure of Human BCMA in complex with UniAb(TM) VH Deposited 2019-01-18 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 6–44(39 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;0.2M sodium malonate pH 4.0 and 20% PEG 3350
Resolution 2.60 Å R-free 0.271
6J7W Crystal Structure of Human BCMA in complex with UniAb(TM) VH Deposited 2019-01-18 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 6–44(39 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4;293 K;0.2M sodium malonate pH 4.0 and 20% PEG 3350
Resolution 2.60 Å R-free 0.271
8HXQ Nanobody1 in complex with human BCMA ECD Deposited 2023-01-05 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain C 1–54(54 aa)
Chain D 1–54(54 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.1;293 K;0.2 M Ammonium sulfate, 20% w/v Polyethylene glycol 3350, pH6.1
Resolution 2.40 Å R-free 0.274
8HXR Nanobody2 in complex with human BCMA ECD Deposited 2023-01-05 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain C 1–54(54 aa)
Chain D 1–54(54 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;1.8 M Sodium acetate trihydrate, 0.1 M Bis-Tris Propane pH7.0
Resolution 2.70 Å R-free 0.287
8QY9 J22.9-H, fully humanized Fab Fragment based on chimeric J22.9-xi IgG against BCMA Deposited 2023-10-25 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 7–41(35 aa)
Not recorded CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293.15 K;14% PEG 3350 100 mM BisTris 7.5 mM Cu(II)
Resolution 3.10 Å R-free 0.301
8QYA J22.9-FNY, fully humanized, CDR optimized Fab Fragment based on chimeric J22.9-xi IgG against BCMA; with VH CDR2 glycosylation Deposited 2023-10-25 Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 6–41(36 aa)
Not recorded CU COPPER (II) ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;PEG 3350 CuCl2 BisTris
Resolution 2.72 Å R-free 0.299
8QYB J22.9-ISY, fully humanized and CDR optimized Fab Fragment based on chimeric J22.9-xi IgG against BCMA Deposited 2023-10-25 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 7–41(35 aa)
Not recorded CU COPPER (II) ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;14% PEG 3350 7.5 mM CuCl2 BisTris
Resolution 3.09 Å R-free 0.288
9MQO Crystal structure of BCMA in complex with CA10v2 Fab Deposited 2025-01-04 Assembly 1 Protein heterocomplex Heteromer;Protein × 18 PDB declaration: 18-meric(18) Consistent with protein count
Chain A 1–54(54 aa)
Chain D 1–54(54 aa)
Chain G 1–54(54 aa)
Chain J 1–54(54 aa)
Chain M 1–54(54 aa)
Chain P 1–54(54 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.18 M Sodium Chloride, 0.09 M Phosphate/citrate pH 4.2, 20 % w/v PEG 8000, 0.1M Sodium Malonate
Resolution 3.18 Å R-free 0.272